Mahmoud Ayman Tarek, Enayet Abdelrhman, Alselisly Ahmed Mohamed Ahmed
Department of Neurosurgery, Kasr Alainy Faculty of Medicine, Cairo University, Giza, Egypt.
Department of Neurosurgery, Cairo University Kasr Alainy Faculty of Medicine, Children Cancer Hospital, Cairo, Egypt.
Surg Neurol Int. 2021 Jun 28;12:310. doi: 10.25259/SNI_318_2021. eCollection 2021.
Brainstem glioma is the leading cause of morbidity and mortality among all central nervous system tumors, especially in childhood as it represents about 20% of all pediatric brain tumors. Therefore, this study aimed to present our experience in a tertiary center in a developing country with limited resources for the surgical management of exophytic brainstem gliomas.
This retrospective study included pediatric patients with brainstem (midbrain, pontine, or medullary) focal or diffuse gliomas whether low or high grade that had dorsal, ventral, or lateral exophytic component who were presented to our hospitals from January 2019 to January 2021. The patients' data were collected, such as age, sex, preoperative and postoperative clinical condition, radiological data, surgical approach, extent of tumor removal, histopathology, follow-up period, and adjuvant therapy.
A total of 23 patients were included in this study. The telovelar approach was used in 17 patients, the supracerebellar infratentorial approach in three patients, and the retrosigmoid, transcerebellar, and occipital transtentorial approach once for each patient. Twenty patients underwent near-total excision, and three underwent subtotal excision. Two-thirds of our cases (17 patients) were low-grade gliomas, with the remaining one-third comprising entirely of either anaplastic astrocytoma (five patients) or glioblastoma multiforme (one patient). The follow-up period of the patients extended from 3 months to 24 months.
Exophytic brainstem glioma surgery can result in good outcomes with minimal complications when near-total excision is attempted through a properly chosen approach and adherence to some surgical techniques and considerations.
脑干胶质瘤是所有中枢神经系统肿瘤中发病和死亡的主要原因,尤其是在儿童期,它约占所有小儿脑肿瘤的20%。因此,本研究旨在介绍我们在一个资源有限的发展中国家的三级中心对外生性脑干胶质瘤进行手术治疗的经验。
这项回顾性研究纳入了2019年1月至2021年1月期间到我们医院就诊的患有脑干(中脑、脑桥或延髓)局灶性或弥漫性胶质瘤的儿科患者,无论肿瘤为低级别还是高级别,且具有背侧、腹侧或外侧外生性成分。收集了患者的数据,如年龄、性别、术前和术后临床状况、放射学数据、手术入路、肿瘤切除范围、组织病理学、随访期和辅助治疗。
本研究共纳入23例患者。17例患者采用经小脑幕入路,3例患者采用小脑上幕下入路,每例患者分别采用乙状窦后、经小脑和枕下经幕入路各1次。20例患者接受了近全切除,3例患者接受了次全切除。我们的病例中有三分之二(17例患者)为低级别胶质瘤,其余三分之一完全由间变性星形细胞瘤(5例患者)或多形性胶质母细胞瘤(1例患者)组成。患者的随访期从3个月延长至24个月。
当通过适当选择入路并遵循一些手术技术和注意事项尝试进行近全切除时,外生性脑干胶质瘤手术可以取得良好的效果,并发症最少。